Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment ...

The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.

This week in oncology has been marked by significant strides in targeted therapies, a re-evaluation of established treatment paradigms, and compelling evidence for the impact of lifestyle ...

In this trial, patients that had residual disease were randomized ... triple-negative breast cancer or hormone receptor positive HER2 negative breast cancer and treated with Olaparib 300 ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

The following is a summary of "Advances and challenges in targeted therapies for HER2-amplified colorectal cancer," published ...